bioresorbable implants market Report Overview
-
Request a Free Sample to learn more about this report
The global bioresorbable implants market size was USD 5735.1 million in 2022. As per our research, the market is expected to reach USD 7425.8 million by 2028, exhibiting a CAGR of 4.4% during the forecast period. The global COVID-19 pandemic has been unprecedented and staggering, with the bioresorbable implants market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.
Bioresorbable implants are medical devices that are made from materials that are eventually broken down and absorbed by the body. These implants are used in a variety of applications. Stents are used to keep blood vessels open. Bioresorbable stents are gradually absorbed by the body over a period of months or years. This reduces the risk of complications such as infection and inflammation, which are common with traditional metal stents.
Bioresorbable stents are made from materials such as polylactic acid (PLA) and polyglycolic acid (PGA). These materials are naturally occurring and biocompatible, meaning that they are not harmful to the body. Bioresorbable stents are also flexible and strong, which makes them suitable for use in blood vessels.
COVID-19 Impact: Pandemic Decreased The Market Demand Due To Non-Prioritization Of Elective Surgeries
The COVID-19 pandemic had a significant impact on the bioresorbable implants market share. During the pandemic, many hospitals and healthcare facilities had to postpone or cancel elective surgeries due to the need to prioritize the treatment of COVID-19 patients. This led to a decline in the demand for them, which are typically used in elective surgeries. The COVID-19 pandemic also caused disruptions to the supply chain for them. This was due to factors such as factory closures, travel restrictions, and delays in transportation. These disruptions made it difficult for manufacturers to get the materials and components they need to produce them. The COVID-19 pandemic also led to an economic slowdown, which reduced the disposable income of many people. This made it more difficult for people to afford elective surgeries, including those that require them.
Latest Trends
"Increasing Demand For Bioresorbable Bone Scaffolds To Fuel The Growth In The Market"
Bioresorbable bone scaffolds are used to repair damaged bones. They are gradually absorbed by the body, which allows new bone tissue to grow. Bioresorbable bone scaffolds can be used to fill bone defects, such as those caused by fractures, tumors, or infections. The scaffold provides a framework for new bone tissue to grow, and it is gradually absorbed by the body over time. Bioresorbable bone scaffolds can be used to stabilize bone grafts, which are pieces of bone that are transplanted from one part of the body to another. The scaffold helps to keep the bone graft in place until it is incorporated into the surrounding bone. Bioresorbable bone scaffolds can be used to induce bone growth in areas where there is not enough bone. The scaffold provides a surface for cells to attach to and start to grow new bone tissue.
bioresorbable implants market Segmentation
-
Request a Free Sample to learn more about this report
- By Type
According to type, the market can be segmented into Metals and Polymers.
- By Application
Based on age, the market can be divided into Stents, Orthopedics and Others.
Driving Factors
"Increasing Demand For Minimally Invasive Surgeries To Foster The Market Growth"
Minimally invasive surgery (MIS) is a surgical procedure that uses small incisions to access the target area. This is in contrast to traditional surgery, which typically requires larger incisions. MIS has a number of advantages over traditional surgery. Patients who undergo MIS typically have a shorter recovery time than those who undergo traditional surgery. This is because the incisions are smaller and there is less tissue damage. Patients who undergo MIS typically experience less pain than those who undergo traditional surgery. This is because the incisions are smaller and there is less tissue damage. The risk of infection is lower with MIS than with traditional surgery. This is because the incisions are smaller and there is less tissue damage. The cosmetic results are often better with MIS than with traditional surgery. This is because the incisions are smaller and they are often hidden in natural folds of the skin. Bioresorbable implants are ideal for MIS because they can be easily inserted and removed through small incisions. This makes them a good option for patients who want to minimize their recovery time and pain.
"Rising Investment In Research And Development To Result In The Expansion Of The Market"
There is a lot of research and development activity in the field of bioresorbable implants. This is due to the potential benefits of these implants. They can reduce the risk of complications such as infection and inflammation. This is because they are made from materials that are compatible with the human body. Bioresorbable implants can improve patient outcomes by reducing the need for revision surgery. This is because they are gradually absorbed by the body, which allows new tissue to grow in their place. Bioresorbable implants can be lower cost than traditional implants in the long run. This is because they do not require revision surgery. The rising investment in research and development is leading to the development of new and improved bioresorbable implants. These new implants are expected to have even more benefits than the current implants.
Restraining Factor
"Manufacturing Challenges To Hamper The Market Growth"
Manufacturing bioresorbable implants can be challenging. The implants must be made with materials that are biocompatible and have the right mechanical properties. The manufacturing process must also be controlled to ensure that the implants are consistent and of high quality.
bioresorbable implants market Regional Insights
-
Request a Free Sample to learn more about this report
"Asia Pacific To Lead The Market Owing To Growing Aging Population In The Region. "
Asia Pacific region has shown the highest bioresorbable implants market growth. The Asia-Pacific region has a large and growing aging population. This is leading to an increase in the number of people with chronic diseases, such as osteoporosis and osteoarthritis. Bioresorbable implants can be used to treat these diseases and improve the quality of life of patients.
Key Industry Players
"Key players are employing advanced technologies in order to stimulate further growth of the market"
All the major players are motivated to offer superior and more advanced services in order to gain a competitive edge in the market. To increase their market presence, vendors are using a variety of techniques, including product launches, regional growth, strategic alliances, partnerships, mergers, and acquisitions.
List of Market Players Profiled
- Bioretec (Germany)
- DePuy Synthes (U.S.)
- Stryker (U.S.)
- Smith & Nephew (U.K.)
- Biomet (U.S.)
- Medtronic (Ireland)
Report Coverage
This report examines an understanding of the bioresorbable implants market’s size, share, growth rate, segmentation by type, application, key players, and previous and current market scenarios. The report also collects the market’s precise data and forecasts by market experts. Also, it describes the study of this industry’s financial performance, investments, growth, innovation marks, and new product launches by the top companies and offers deep insights into the current market structure, competitive analysis based on key players, key driving forces, and restraints that affect the demand for growth, opportunities, and risks.
Furthermore, the post-COVID-19 pandemic’s effects on international market restrictions and a deep understanding of how the industry will recover, and strategies are also stated in the report. The competitive landscape has also been examined in detail to provide clarification of the competitive landscape.
This report also discloses the research based on methodologies that define price trend analysis of target companies, collection of data, statistics, target competitors, import-export, information, and previous years’ records based on market sales. Moreover, all the significant factors which influence the market such as small or medium business industry, macro-economic indicators, value chain analysis, and demand-side dynamics, with all the major business players have been explained in detail. This analysis is subject to modification if the key players and feasible analysis of market dynamics change.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 5735.1 Million in 2022 |
Market Size Value By |
US$ 7425.8 Million by 2028 |
Growth Rate |
CAGR of 4.4% from 2022 to 2028 |
Forecast Period |
2022-2028 |
Base Year |
2022 |
Historical Data Available |
Yes |
Segments Covered |
Type and Application |
Regional Scope |
Global |
Frequently Asked Questions
-
What value is the bioresorbable implants market expected to touch by 2028?
The bioresorbable implants market is expected to touch USD 7425.8 million by 2028.
-
What CAGR is the bioresorbable implants market expected to exhibit during 2022-2028?
The bioresorbable implants market is expected to exhibit a CAGR of 4.4% over 2022-2028.
-
Which are the driving factors of the bioresorbable implants market?
The driving factors of the bioresorbable implants market are increasing demand for minimally invasive surgeries and rising investment in research and development.
-
Which are the top companies operating in the bioresorbable implants market?
The top companies operating in the bioresorbable implants market are Bioretec, DePuy Synthes, Stryker, Smith & Nephew, Biomet, Medtronic